CN104474129A - Medicinal formula for treating coronary heart disease and use method thereof - Google Patents
Medicinal formula for treating coronary heart disease and use method thereof Download PDFInfo
- Publication number
- CN104474129A CN104474129A CN201410691260.8A CN201410691260A CN104474129A CN 104474129 A CN104474129 A CN 104474129A CN 201410691260 A CN201410691260 A CN 201410691260A CN 104474129 A CN104474129 A CN 104474129A
- Authority
- CN
- China
- Prior art keywords
- radix
- heart disease
- coronary heart
- use method
- treating coronary
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 208000029078 coronary artery disease Diseases 0.000 title claims abstract description 25
- 238000000034 method Methods 0.000 title claims abstract description 17
- 239000003814 drug Substances 0.000 claims abstract description 34
- 238000011282 treatment Methods 0.000 claims abstract description 15
- 241001619461 Poria <basidiomycete fungus> Species 0.000 claims description 14
- 241000756943 Codonopsis Species 0.000 claims description 11
- 239000009636 Huang Qi Substances 0.000 claims description 10
- 230000003203 everyday effect Effects 0.000 claims description 6
- 239000008194 pharmaceutical composition Substances 0.000 claims description 2
- 230000000694 effects Effects 0.000 abstract description 18
- 239000008280 blood Substances 0.000 abstract description 15
- 210000004369 blood Anatomy 0.000 abstract description 14
- 230000001737 promoting effect Effects 0.000 abstract description 9
- 230000017531 blood circulation Effects 0.000 abstract description 7
- 229940079593 drug Drugs 0.000 abstract description 7
- 230000006870 function Effects 0.000 abstract description 6
- 210000003734 kidney Anatomy 0.000 abstract description 6
- 208000024172 Cardiovascular disease Diseases 0.000 abstract description 3
- 208000026106 cerebrovascular disease Diseases 0.000 abstract description 3
- 235000013399 edible fruits Nutrition 0.000 abstract description 3
- 230000002526 effect on cardiovascular system Effects 0.000 abstract description 3
- 238000005728 strengthening Methods 0.000 abstract description 3
- 244000241838 Lycium barbarum Species 0.000 abstract description 2
- 235000015459 Lycium barbarum Nutrition 0.000 abstract description 2
- 241000045403 Astragalus propinquus Species 0.000 abstract 1
- 244000037364 Cinnamomum aromaticum Species 0.000 abstract 1
- 235000014489 Cinnamomum aromaticum Nutrition 0.000 abstract 1
- 241000007126 Codonopsis pilosula Species 0.000 abstract 1
- 241001289529 Fallopia multiflora Species 0.000 abstract 1
- 244000303040 Glycyrrhiza glabra Species 0.000 abstract 1
- 235000006200 Glycyrrhiza glabra Nutrition 0.000 abstract 1
- 235000017443 Hedysarum boreale Nutrition 0.000 abstract 1
- 235000007858 Hedysarum occidentale Nutrition 0.000 abstract 1
- 241000112528 Ligusticum striatum Species 0.000 abstract 1
- 235000015468 Lycium chinense Nutrition 0.000 abstract 1
- 244000197580 Poria cocos Species 0.000 abstract 1
- 235000008599 Poria cocos Nutrition 0.000 abstract 1
- 241000304195 Salvia miltiorrhiza Species 0.000 abstract 1
- 235000011135 Salvia miltiorrhiza Nutrition 0.000 abstract 1
- 235000006533 astragalus Nutrition 0.000 abstract 1
- 238000007599 discharging Methods 0.000 abstract 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 abstract 1
- 210000004185 liver Anatomy 0.000 description 8
- 208000002193 Pain Diseases 0.000 description 6
- 208000004880 Polyuria Diseases 0.000 description 5
- 239000003146 anticoagulant agent Substances 0.000 description 5
- 230000007812 deficiency Effects 0.000 description 5
- 230000035619 diuresis Effects 0.000 description 5
- 201000010099 disease Diseases 0.000 description 4
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 4
- 230000036407 pain Effects 0.000 description 4
- 210000000952 spleen Anatomy 0.000 description 4
- 238000002560 therapeutic procedure Methods 0.000 description 4
- 206010002383 Angina Pectoris Diseases 0.000 description 3
- 208000006820 Arthralgia Diseases 0.000 description 3
- 208000031481 Pathologic Constriction Diseases 0.000 description 3
- 208000027418 Wounds and injury Diseases 0.000 description 3
- 235000009508 confectionery Nutrition 0.000 description 3
- 230000006378 damage Effects 0.000 description 3
- 208000014674 injury Diseases 0.000 description 3
- 244000052769 pathogen Species 0.000 description 3
- 230000001717 pathogenic effect Effects 0.000 description 3
- 239000000341 volatile oil Substances 0.000 description 3
- 206010061218 Inflammation Diseases 0.000 description 2
- 241000238370 Sepia Species 0.000 description 2
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 description 2
- 244000061456 Solanum tuberosum Species 0.000 description 2
- 235000002595 Solanum tuberosum Nutrition 0.000 description 2
- 230000009471 action Effects 0.000 description 2
- 230000036592 analgesia Effects 0.000 description 2
- 208000007502 anemia Diseases 0.000 description 2
- 230000000844 anti-bacterial effect Effects 0.000 description 2
- 230000000702 anti-platelet effect Effects 0.000 description 2
- 230000002785 anti-thrombosis Effects 0.000 description 2
- 208000006673 asthma Diseases 0.000 description 2
- 230000003143 atherosclerotic effect Effects 0.000 description 2
- 230000001914 calming effect Effects 0.000 description 2
- 210000004351 coronary vessel Anatomy 0.000 description 2
- 238000002651 drug therapy Methods 0.000 description 2
- 230000002708 enhancing effect Effects 0.000 description 2
- 239000000796 flavoring agent Substances 0.000 description 2
- 235000019634 flavors Nutrition 0.000 description 2
- OVBPIULPVIDEAO-LBPRGKRZSA-N folic acid Chemical compound C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-LBPRGKRZSA-N 0.000 description 2
- 239000007789 gas Substances 0.000 description 2
- 210000004209 hair Anatomy 0.000 description 2
- 208000019622 heart disease Diseases 0.000 description 2
- 208000013403 hyperactivity Diseases 0.000 description 2
- 230000036039 immunity Effects 0.000 description 2
- 230000004054 inflammatory process Effects 0.000 description 2
- 206010022437 insomnia Diseases 0.000 description 2
- 230000000302 ischemic effect Effects 0.000 description 2
- 210000004072 lung Anatomy 0.000 description 2
- 239000000203 mixture Substances 0.000 description 2
- 230000002107 myocardial effect Effects 0.000 description 2
- 208000031225 myocardial ischemia Diseases 0.000 description 2
- 230000003449 preventive effect Effects 0.000 description 2
- 239000000047 product Substances 0.000 description 2
- 230000001047 pyretic effect Effects 0.000 description 2
- 230000036262 stenosis Effects 0.000 description 2
- 208000037804 stenosis Diseases 0.000 description 2
- 208000011580 syndromic disease Diseases 0.000 description 2
- DWNBOPVKNPVNQG-LURJTMIESA-N (2s)-4-hydroxy-2-(propylamino)butanoic acid Chemical compound CCCN[C@H](C(O)=O)CCO DWNBOPVKNPVNQG-LURJTMIESA-N 0.000 description 1
- MCSXGCZMEPXKIW-UHFFFAOYSA-N 3-hydroxy-4-[(4-methyl-2-nitrophenyl)diazenyl]-N-(3-nitrophenyl)naphthalene-2-carboxamide Chemical compound Cc1ccc(N=Nc2c(O)c(cc3ccccc23)C(=O)Nc2cccc(c2)[N+]([O-])=O)c(c1)[N+]([O-])=O MCSXGCZMEPXKIW-UHFFFAOYSA-N 0.000 description 1
- CJIJXIFQYOPWTF-UHFFFAOYSA-N 7-hydroxycoumarin Natural products O1C(=O)C=CC2=CC(O)=CC=C21 CJIJXIFQYOPWTF-UHFFFAOYSA-N 0.000 description 1
- 208000004476 Acute Coronary Syndrome Diseases 0.000 description 1
- 201000004384 Alopecia Diseases 0.000 description 1
- 201000000736 Amenorrhea Diseases 0.000 description 1
- 206010001928 Amenorrhoea Diseases 0.000 description 1
- 206010002660 Anoxia Diseases 0.000 description 1
- 241000976983 Anoxia Species 0.000 description 1
- 208000008035 Back Pain Diseases 0.000 description 1
- 206010007247 Carbuncle Diseases 0.000 description 1
- 229920000832 Cutin Polymers 0.000 description 1
- 208000005171 Dysmenorrhea Diseases 0.000 description 1
- 206010013935 Dysmenorrhoea Diseases 0.000 description 1
- 206010013954 Dysphoria Diseases 0.000 description 1
- 208000005189 Embolism Diseases 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 208000004930 Fatty Liver Diseases 0.000 description 1
- 241000628997 Flos Species 0.000 description 1
- 229940121710 HMGCoA reductase inhibitor Drugs 0.000 description 1
- 206010019233 Headaches Diseases 0.000 description 1
- 206010019280 Heart failures Diseases 0.000 description 1
- 102000001554 Hemoglobins Human genes 0.000 description 1
- 108010054147 Hemoglobins Proteins 0.000 description 1
- 208000032843 Hemorrhage Diseases 0.000 description 1
- 206010019708 Hepatic steatosis Diseases 0.000 description 1
- 208000031226 Hyperlipidaemia Diseases 0.000 description 1
- 206010021143 Hypoxia Diseases 0.000 description 1
- 229930194542 Keto Natural products 0.000 description 1
- 208000008930 Low Back Pain Diseases 0.000 description 1
- 208000019255 Menstrual disease Diseases 0.000 description 1
- OVBPIULPVIDEAO-UHFFFAOYSA-N N-Pteroyl-L-glutaminsaeure Natural products C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)NC(CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-UHFFFAOYSA-N 0.000 description 1
- 229910002651 NO3 Inorganic materials 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 208000008589 Obesity Diseases 0.000 description 1
- 241000283973 Oryctolagus cuniculus Species 0.000 description 1
- 244000170916 Paeonia officinalis Species 0.000 description 1
- 235000006484 Paeonia officinalis Nutrition 0.000 description 1
- 206010034568 Peripheral coldness Diseases 0.000 description 1
- 235000008331 Pinus X rigitaeda Nutrition 0.000 description 1
- 235000011613 Pinus brutia Nutrition 0.000 description 1
- 241000018646 Pinus brutia Species 0.000 description 1
- 208000001431 Psychomotor Agitation Diseases 0.000 description 1
- 206010037660 Pyrexia Diseases 0.000 description 1
- 241000218201 Ranunculaceae Species 0.000 description 1
- 206010038743 Restlessness Diseases 0.000 description 1
- 208000025747 Rheumatic disease Diseases 0.000 description 1
- 241001558929 Sclerotium <basidiomycota> Species 0.000 description 1
- 241000208292 Solanaceae Species 0.000 description 1
- 206010042434 Sudden death Diseases 0.000 description 1
- 208000001435 Thromboembolism Diseases 0.000 description 1
- 208000009205 Tinnitus Diseases 0.000 description 1
- 208000012886 Vertigo Diseases 0.000 description 1
- 210000001015 abdomen Anatomy 0.000 description 1
- 230000003213 activating effect Effects 0.000 description 1
- 201000009961 allergic asthma Diseases 0.000 description 1
- 231100000360 alopecia Toxicity 0.000 description 1
- 231100000540 amenorrhea Toxicity 0.000 description 1
- 230000007953 anoxia Effects 0.000 description 1
- 230000008485 antagonism Effects 0.000 description 1
- 230000001093 anti-cancer Effects 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 230000003064 anti-oxidating effect Effects 0.000 description 1
- 230000003471 anti-radiation Effects 0.000 description 1
- 230000002180 anti-stress Effects 0.000 description 1
- 230000000259 anti-tumor effect Effects 0.000 description 1
- 229940127219 anticoagulant drug Drugs 0.000 description 1
- 210000001367 artery Anatomy 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 239000002876 beta blocker Substances 0.000 description 1
- 229940097320 beta blocking agent Drugs 0.000 description 1
- 230000033228 biological regulation Effects 0.000 description 1
- 230000000740 bleeding effect Effects 0.000 description 1
- 230000036772 blood pressure Effects 0.000 description 1
- 210000004204 blood vessel Anatomy 0.000 description 1
- 210000001124 body fluid Anatomy 0.000 description 1
- 239000010839 body fluid Substances 0.000 description 1
- 230000037396 body weight Effects 0.000 description 1
- 210000000988 bone and bone Anatomy 0.000 description 1
- 210000000481 breast Anatomy 0.000 description 1
- 230000009172 bursting Effects 0.000 description 1
- 201000011510 cancer Diseases 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- OEYIOHPDSNJKLS-UHFFFAOYSA-N choline Chemical compound C[N+](C)(C)CCO OEYIOHPDSNJKLS-UHFFFAOYSA-N 0.000 description 1
- 229960001231 choline Drugs 0.000 description 1
- 230000001684 chronic effect Effects 0.000 description 1
- 230000000295 complement effect Effects 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 230000007423 decrease Effects 0.000 description 1
- 238000001784 detoxification Methods 0.000 description 1
- 230000000916 dilatatory effect Effects 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 210000003414 extremity Anatomy 0.000 description 1
- 208000010706 fatty liver disease Diseases 0.000 description 1
- 239000012467 final product Substances 0.000 description 1
- 229960000304 folic acid Drugs 0.000 description 1
- 235000019152 folic acid Nutrition 0.000 description 1
- 239000011724 folic acid Substances 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 230000004345 fruit ripening Effects 0.000 description 1
- 231100000869 headache Toxicity 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 206010019847 hepatosplenomegaly Diseases 0.000 description 1
- IPCSVZSSVZVIGE-UHFFFAOYSA-N hexadecanoic acid Chemical compound CCCCCCCCCCCCCCCC(O)=O IPCSVZSSVZVIGE-UHFFFAOYSA-N 0.000 description 1
- 239000005556 hormone Substances 0.000 description 1
- 229940088597 hormone Drugs 0.000 description 1
- 239000002471 hydroxymethylglutaryl coenzyme A reductase inhibitor Substances 0.000 description 1
- 230000036737 immune function Effects 0.000 description 1
- 229960003444 immunosuppressant agent Drugs 0.000 description 1
- 230000001861 immunosuppressant effect Effects 0.000 description 1
- 239000003018 immunosuppressive agent Substances 0.000 description 1
- 238000000338 in vitro Methods 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 230000001788 irregular Effects 0.000 description 1
- 208000028867 ischemia Diseases 0.000 description 1
- 125000000468 ketone group Chemical group 0.000 description 1
- 230000003907 kidney function Effects 0.000 description 1
- 210000003127 knee Anatomy 0.000 description 1
- 150000002596 lactones Chemical class 0.000 description 1
- 230000003902 lesion Effects 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 235000014659 low sodium diet Nutrition 0.000 description 1
- 235000004213 low-fat Nutrition 0.000 description 1
- 230000014759 maintenance of location Effects 0.000 description 1
- 201000004792 malaria Diseases 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 208000007106 menorrhagia Diseases 0.000 description 1
- 210000004914 menses Anatomy 0.000 description 1
- 230000002175 menstrual effect Effects 0.000 description 1
- 235000010755 mineral Nutrition 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 210000003205 muscle Anatomy 0.000 description 1
- 208000010125 myocardial infarction Diseases 0.000 description 1
- 210000004165 myocardium Anatomy 0.000 description 1
- 210000005036 nerve Anatomy 0.000 description 1
- -1 nitrate esters Chemical class 0.000 description 1
- 239000000346 nonvolatile oil Substances 0.000 description 1
- 231100000862 numbness Toxicity 0.000 description 1
- 235000020824 obesity Nutrition 0.000 description 1
- 230000008520 organization Effects 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 230000036284 oxygen consumption Effects 0.000 description 1
- 230000003119 painkilling effect Effects 0.000 description 1
- 231100000915 pathological change Toxicity 0.000 description 1
- 230000036285 pathological change Effects 0.000 description 1
- 230000003836 peripheral circulation Effects 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 230000001681 protective effect Effects 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 230000000250 revascularization Effects 0.000 description 1
- 230000000552 rheumatic effect Effects 0.000 description 1
- 230000000630 rising effect Effects 0.000 description 1
- 206010040872 skin infection Diseases 0.000 description 1
- 230000005586 smoking cessation Effects 0.000 description 1
- 208000010110 spontaneous platelet aggregation Diseases 0.000 description 1
- 231100000240 steatosis hepatitis Toxicity 0.000 description 1
- 210000002784 stomach Anatomy 0.000 description 1
- 230000004206 stomach function Effects 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 239000013589 supplement Substances 0.000 description 1
- 230000001502 supplementing effect Effects 0.000 description 1
- 238000001356 surgical procedure Methods 0.000 description 1
- 210000002435 tendon Anatomy 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 231100000886 tinnitus Toxicity 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- 230000002936 tranquilizing effect Effects 0.000 description 1
- 210000005239 tubule Anatomy 0.000 description 1
- 230000004614 tumor growth Effects 0.000 description 1
- ORHBXUUXSCNDEV-UHFFFAOYSA-N umbelliferone Chemical compound C1=CC(=O)OC2=CC(O)=CC=C21 ORHBXUUXSCNDEV-UHFFFAOYSA-N 0.000 description 1
- HFTAFOQKODTIJY-UHFFFAOYSA-N umbelliferone Natural products Cc1cc2C=CC(=O)Oc2cc1OCC=CC(C)(C)O HFTAFOQKODTIJY-UHFFFAOYSA-N 0.000 description 1
- 210000003932 urinary bladder Anatomy 0.000 description 1
- 210000001215 vagina Anatomy 0.000 description 1
- 210000003462 vein Anatomy 0.000 description 1
- 231100000889 vertigo Toxicity 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 150000003722 vitamin derivatives Chemical class 0.000 description 1
- 238000010792 warming Methods 0.000 description 1
- 230000002087 whitening effect Effects 0.000 description 1
- 230000037303 wrinkles Effects 0.000 description 1
- 239000008945 zhigancao decoction Substances 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/34—Campanulaceae (Bellflower family)
- A61K36/344—Codonopsis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/06—Fungi, e.g. yeasts
- A61K36/07—Basidiomycota, e.g. Cryptococcus
- A61K36/076—Poria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
- A61K36/232—Angelica
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
- A61K36/236—Ligusticum (licorice-root)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
- A61K36/284—Atractylodes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/29—Berberidaceae (Barberry family), e.g. barberry, cohosh or mayapple
- A61K36/296—Epimedium
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/481—Astragalus (milkvetch)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/484—Glycyrrhiza (licorice)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
- A61K36/537—Salvia (sage)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/54—Lauraceae (Laurel family), e.g. cinnamon or sassafras
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/70—Polygonaceae (Buckwheat family), e.g. spineflower or dock
- A61K36/704—Polygonum, e.g. knotweed
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/71—Ranunculaceae (Buttercup family), e.g. larkspur, hepatica, hydrastis, columbine or goldenseal
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/81—Solanaceae (Potato family), e.g. tobacco, nightshade, tomato, belladonna, capsicum or jimsonweed
- A61K36/815—Lycium (desert-thorn)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
- A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/33—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
- A61K2236/331—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using water, e.g. cold water, infusion, tea, steam distillation or decoction
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Mycology (AREA)
- Engineering & Computer Science (AREA)
- Microbiology (AREA)
- Medical Informatics (AREA)
- Botany (AREA)
- Biotechnology (AREA)
- Alternative & Traditional Medicine (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
The invention relates to the technical field of medicines and particularly discloses a medicinal formula for treating coronary heart disease and a use method thereof. The use method comprises the following step: after proportioning 20g of codonopsis pilosula, 30g of astragalus membranaceus, 15g of ligusticum wallichii, 15g of fruits of wolfberries, 15g of radix polygonum multiflorum preparata, 15g of moutan barks, 25g of salvia miltiorrhiza, 10g of roasted rhizoma atractylodis macrocephalae, 10g of poria cocos, 10g of herba epimedii, 10g of cassia twig, 20g of radix angelicae sineinsis and 8g of honey-fried licorice roots, decocting with water, one dosage a day which is orally taken by one to two times, wherein a treatment course comprises 20 days. The invention aims to provide the medicinal formula for treating coronary heart disease and the use method thereof. The medicinal formula for treating coronary heart disease has a very good effect and meanwhile has the functions of strengthening the middle warmer and nourishing kidney, promoting blood circulation to remove blood stasis and isolating clear and discharging turbid, and further has effects of treating and preventing cardiovascular and cerebrovascular diseases.
Description
Technical field
The present invention relates to technical field of pharmaceuticals, specifically disclose one and treat medicaments for coronary disease formula and using method thereof.
Background technology
Coronary atherosclerotic heart disease is coronary artery generation atherosclerotic lesion and causes lumen of vessels stenosis or occlusion, causes myocardial ischemia, anoxia or downright bad and heart disease that is that cause, is usually called as " coronary heart disease ".But the scope of coronary heart disease may be more extensive, also comprises inflammation, thromboembolism etc. and cause luminal stenosis or obturation.Coronary heart disease is divided into 5 large classes by World Health Organization (WHO): silent ischemia (latent coronary heart disease), angina pectoris, myocardial infarction, ischemic heart failure (ischemic heart desease) and sudden death 5 kinds of Clinical types.Stable coronary heart disease and acute coronary syndrome is usually divided in clinical.
The treatment of coronary heart disease comprises: 1. living habit changes: smoking cessation limit wine, low-fat low-salt diet, and suitable physical training, controls body weight etc.; 2. Drug therapy: antithrombotic (antiplatelet, anticoagulant), alleviates myocardium keto consumption (beta-blocker), allevating angina pectoris (nitrate esters), adjusts fat stabilize plaque (Statins fat regulation medicine); 3. myocardial revascularization treatment: comprise interventional therapy (intravascular balloon expansion plasty and Stent) and surgery coronary artery bypass grafting.Drug therapy is the basis of all treatments.Get involved and also will adhere to long-term standard medication therapy after surgical operation therapy.Concerning same patient, when being in some stages of disease, available drugs controls ideally, and alone medication effect is often not good when another stage, needs medicine and interventional therapy or surgical operation to share.
Existing medicine is mostly Western medicine, very large to human injury, and effect is not fine.
Summary of the invention
In order to solve the technical problem existed in prior art, one is the object of the present invention is to provide to treat medicaments for coronary disease formula and using method thereof, be 20g by Radix Codonopsis, the Radix Astragali is 30g, Rhizoma Chuanxiong is 15g, Fructus Lycii is 15g, Radix Polygoni Multiflori Preparata is 15g, Cortex Moutan is 15g, Radix Salviae Miltiorrhizae is 25g, Rhizoma Atractylodis Macrocephalae (parched) is 10g, Poria is 10g, Herba Epimedii is 10g, Ramulus Cinnamomi is 10g, Radix Angelicae Sinensis is 20g, Radix Glycyrrhizae Preparata is after 8g proportioning, decocting, every day 1 dose, point 1 to 2 time oral, it within 20 days, is a course for the treatment of, with Radix Codonopsis, the Radix Astragali 3, Rhizoma Chuanxiong, Fructus Lycii is, Radix Polygoni Multiflori Preparata is effect that principal agent has good blood circulation promoting and blood stasis dispelling and isolates clear and discharge turbid, extraordinary effect is had to treatment coronary heart disease, also has invigorating middle warmer kidney tonifying simultaneously, treatment and preventive effect is had to cardiovascular and cerebrovascular disease.
The technical solution adopted in the present invention is as follows:
One treats medicaments for coronary disease formula and using method thereof, it is characterized in that: described pharmaceutical formulation comprises Radix Codonopsis 15-25g, Radix Astragali 25-35g, Rhizoma Chuanxiong 10-20g, Fructus Lycii 10-20g, Radix Polygoni Multiflori Preparata 10-20g, Cortex Moutan 10-20g, Radix Salviae Miltiorrhizae 20-30g, Rhizoma Atractylodis Macrocephalae (parched) 5-15g, Poria 5-15g, Herba Epimedii 5-15g, Ramulus Cinnamomi 5-15g, Radix Angelicae Sinensis 15-25g, Radix Glycyrrhizae Preparata 5-10g.
Further, described Radix Codonopsis is 20g, and the Radix Astragali is 30g, and Rhizoma Chuanxiong is 15g, and Fructus Lycii is 15g, and Radix Polygoni Multiflori Preparata is 15g, and Cortex Moutan is 15g, and Radix Salviae Miltiorrhizae is 25g, and Rhizoma Atractylodis Macrocephalae (parched) is 10g, and Poria is 10g, and Herba Epimedii is 10g, and Ramulus Cinnamomi is 10g, and Radix Angelicae Sinensis is 20g, and Radix Glycyrrhizae Preparata is 8g.
Further, described using method is by after said medicine on request proportioning, decocting, every day 1 dose, and point 1 to 2 time oral, within 20 days, is a course for the treatment of.
The sheet of Radix Codonopsis ovalize or similar round, surperficial yellowish-brown or lark, tangent plane yellow-white or yellowish-brown, have crack or Flos Chrysanthemi stricture of vagina, there are the faint yellow center of circle in central authorities.Periphery yellowish white puts yellowish-brown, has vertical wrinkle.Have special aroma, taste is micro-sweet.Raw Radix Codonopsis sheet supplementing QI for promoting the production of body fluid power victory.Be usually used in gas Tianjin two to hinder or deficiency of both QI and blood.
The Radix Astragali has enhancing human body immunity function, protects the liver, diuresis, defying age, anti-stress, blood pressure lowering and antibacterial action more widely.But table excess pathogen is contained, retention of dampness due to stagnation of QI, and food stagnation is stagnated, carbuncle from the beginning of or the excess syndrome such as pyretic toxicity Shang Sheng after bursting, and hyperactivity of YANG due to deficiency of YIN person, must prohibit clothes.
Rhizoma Chuanxiong is a kind of Chinese medicinal plant, is usually used in blood-activating and qi-promoting, wind-expelling pain-stopping, and the pungent temperature of Rhizoma Chuanxiong is fragrant dry, walks and does not keep, can go loose, and the up mountain peak that reaches is pushed up; Enter blood system again, descendingly reach the sea of blood.Blood circulation promoting and blood stasis dispelling effect is extensive, the suitable various disease of stagnation of blood stasis; Wind-expelling pain-stopping, effectiveness is excellent, can control the diseases such as wind syndrome of head headache, rheumatic arthralgia.It is gas medicine in blood that former times people calls Rhizoma Chuanxiong, the functions such as pungent loose, the resolving depression of its residence of dangerous speech, sensible, pain relieving.The pungent temperature rise of this product is fallen apart, and all hyperactivity of YANG due to deficiency of YIN and excessive rising of liver-YANG person should not apply; Menorrhagia, anemia of pregnant woman also avoid use.
Fructus Lycii is the mature fruit of matrimony vine of solanaceae plant.Pluck when summer, autumn fruit maturation, removing fruit stem, put after shady and cool place dries in the air and corrugate to peel, then be exposed to the sun stiff to crust, sarcocarp is soft and get final product.Meet overcast and rainy available low baking temperature to dry.
Radix Polygoni Multiflori Preparata, the Preparation process product of Radix Polygoni Multiflori, manufactured goods are the block sheet of irregular shrunk, thick about 1cm.Surface pitchy or sepia, uneven.Matter is hard, section cutin sample, sepia or black.Feeble QI, taste is micro-sweet and pained.Bitter, sweet, puckery, temperature.Return liver, the heart, kidney channel.There is invigorating the liver and kidney, benefiting essence-blood, black beard and hair, bone and muscle strengthening effect.For blood deficiency and yellow complexion, vertigo and tinnitus, early whitening of beard and hair, soreness of the waist and knees, numb limbs and tense tendons, bleeding not during menses, chronic malaria body is empty; Hyperlipidemia.Main suitable population is fatty liver, three-hypers, obesity, insomnia, alopecia, teen-ager leukotrichia and sub-health population.
Cortex Moutan, Chinese medicine name.For the dry root bark of ranunculaceae peony.Originate in the ground such as Anhui, Sichuan, Henan, Shandong.There is the effects such as clearing away heat and cooling blood, activating blood circulation to dissipate blood stasis, reducing the asthenic fever.
Radix Salviae Miltiorrhizae, its root is a kind of Chinese medicine.Nature and flavor are bitter, are slightly cold.GUIXIN, Liver Channel.There is stasis-dispelling and pain-killing, promoting blood circulation to restore menstrual flow, the effect of the relieving restlessness that clears away heart-fire.For menoxenia, amenorrhea dysmenorrhea, lump in the abdomen, breast ventral spine pain, pyretic arthralgia pain, skin infection swells and ache, dysphoria and insomnia; Hepatosplenomegaly, angina pectoris.
Rhizoma Atractylodis Macrocephalae (parched) is a kind of qi-restoratives medicine, and rhizome has a kind of volatile oil compounds, has the multiple use such as invigorating spleen for diuresis.Rhizoma Atractylodis Macrocephalae (parched) is through the Rhizoma Atractylodis Macrocephalae of parch.
Poria has another name called: beautiful spirit, Fu Tu, Poria, and Fu Ling, Fu Ling, volt Tu, pine fat, deep red morning lies prostrate tire, Poria, Fu rabbit, loose potato, Masson Pine potato, Song Ling.Medicinal part is the sclerotium of On Polyporaceae Poria.There is promoting diuresis to eliminate damp pathogen, spleen invigorating, the effect of calming the nerves.Can also be made into powdery be used for Ms hobby cleawhite pack.Distributed areas: Jilin, Anhui, Zhejiang, Fujian, Henan, Hubei, Guangxi, Sichuan, Guizhou, Yunnan.Ancients claim Poria to be " when four god medicine ", because its effect widely, regardless of the four seasons, by it and various compatibility of drugs, no matter cold, temperature, wind, wet all diseases, can play its unique effects.Poria sweet in the mouth, light, property are put down, and are used as medicine and have the function of promoting diuresis to eliminate damp pathogen, strengthening the spleen stomach function regulating, mind tranquilizing and the heart calming.Modern medicine study: Poria energy enhancing human body immunity function, pachyman has obvious antitumor and protects the liver dirty effect.But deficiency and coldness essence is sliding or collapse of QI person avoids clothes.
Herba Epimedii, treats the numbness of wind and cold, and nourishing YIN is empty and supporing yang.
Ramulus Cinnamomi, its nature and flavor are pungent, sweet, temperature, enter lung, the heart, urinary bladder channel, be cure mainly the conventional drugs for dispelling internal cold of interior cold, there is effect of complement sun, promoting blood circulation, warming the spleen and stomach, normal and invigorating the liver and kidney medicine, fill blood medicine compatibility, treatment insufficiency of kidney-YANG, decline of the fire from the gate of life, cold extremities faint pulse, treat coldness and pain in the epigastrium, arthralgia due to cold lumbago with other drugs for dispelling internal cold compatibility, has the effect of significantly analgesia and anti-cancer and cancer-preventing.
The chemical composition of Radix Angelicae Sinensis is mainly volatile oil, is extremely wherein the main component in volatile oil in Rhizoma Ligustici.Fixed oil composition has newly returns lactone, Palmic acid, folic acid, hyoscyami Roripa, umbelliferone and choline, and latter 3 kinds is effective content of anti inflammation.In addition containing multiple propylhomoserin, vitamin and mineral.There is the physiological action of following aspect: anti-platelet aggregation and antithrombotic, hemoglobin and erythrocytic generation can be promoted, anti-anemia action; Blood vessel dilating, improves peripheral circulation, reduces low myocardial oxygen consumption, increases oxygen carrying capacity, resists myocardial ischemia, blood fat reducing; Protect the liver, strengthen the function of detoxification of liver; Diuresis, improves renal function, promotes the recovery of renal tubules pathological changes; Calmness, analgesia, antiinflammatory, antioxidation, Antiradiation injury; There is protective effect to injury of lung, relieving asthma, antagonism allergic asthma; Strengthen immunologic function, the immunosuppressant that saccharic hormone causes can be resisted; Have and suppress some tumor growth with the effect of in-vitro antibacterial.
Radix Glycyrrhizae Preparata is similar round or oval section, and the brown or taupe brown of surface red, micro-glossy, tangent plane is yellow to buff, and cambium ring is obvious, ray irradiation shape.Zhigancao decoction has benefiting qi and nourishing yin, and activate yang multiple arteries and veins therapeutic efficiency.
The invention provides one and treat medicaments for coronary disease formula and using method thereof, its beneficial effect shows:
Have extraordinary effect to treatment coronary heart disease, also have invigorating middle warmer kidney tonifying, blood circulation promoting and blood stasis dispelling, isolates clear and discharge turbid simultaneously, has treatment and preventive effect to cardiovascular and cerebrovascular disease.
Detailed description of the invention
Below in conjunction with embodiment, the present invention is further illustrated.
Embodiment 1
One treats medicaments for coronary disease formula and using method thereof, by Radix Codonopsis 20g, and Radix Astragali 30g, Rhizoma Chuanxiong 15g, Fructus Lycii is 15g, Radix Polygoni Multiflori Preparata 15g, Cortex Moutan 15g, Radix Salviae Miltiorrhizae 25g, Rhizoma Atractylodis Macrocephalae (parched) 10g, Poria 10g, Herba Epimedii 10g, Ramulus Cinnamomi 10g, after Radix Angelicae Sinensis 20g, Radix Glycyrrhizae Preparata 8g proportioning, decocting, every day 1 dose, point 1 to 2 time oral, within 20 days, is a course for the treatment of.
Embodiment 2
Wang, man 54 years old, people from Anhui, suffers from coronary heart disease for many years, expensive money large hospital to treat 1 year fail always complete, treatment medicaments for coronary disease formula provided by the invention and using method thereof is brought into use from April, 2013, by Radix Codonopsis 20g, Radix Astragali 30g, Rhizoma Chuanxiong 15g, Fructus Lycii is 15g, Radix Polygoni Multiflori Preparata 15g, Cortex Moutan 15g, Radix Salviae Miltiorrhizae 25g, Rhizoma Atractylodis Macrocephalae (parched) 10g, Poria 10g, Herba Epimedii 10g, Ramulus Cinnamomi 10g, Radix Angelicae Sinensis 20g, after Radix Glycyrrhizae Preparata 8g proportioning, decocting, every day 1 dose, point 1 to 2 time oral, examination in hospital is removed after 60 days, the state of an illness takes an evident turn for the better.
Embodiment 3
Mrs Li, female 52 years old, people from Anhui, suffers from coronary heart disease for many years, expensive money large hospital to treat 1 year fail always complete, treatment medicaments for coronary disease formula provided by the invention and using method thereof is brought into use from June, 2013, by Radix Codonopsis 20g, Radix Astragali 30g, Rhizoma Chuanxiong 15g, Fructus Lycii is 15g, Radix Polygoni Multiflori Preparata 15g, Cortex Moutan 15g, Radix Salviae Miltiorrhizae 25g, Rhizoma Atractylodis Macrocephalae (parched) 10g, Poria 10g, Herba Epimedii 10g, Ramulus Cinnamomi 10g, Radix Angelicae Sinensis 20g, after Radix Glycyrrhizae Preparata 8g proportioning, decocting, every day 1 dose, point 1 to 2 time oral, examination in hospital is removed after 80 days, the state of an illness takes an evident turn for the better.
Above content is only conceive example and explanation to the present invention; affiliated those skilled in the art make various amendment to described specific embodiment or supplement or adopt similar mode to substitute; only otherwise depart from the design of invention or surmount this scope as defined in the claims, protection scope of the present invention all should be belonged to.
Claims (3)
1. treat medicaments for coronary disease formula and a using method thereof, it is characterized in that: described pharmaceutical formulation comprises Radix Codonopsis 15-25g, Radix Astragali 25-35g, Rhizoma Chuanxiong 10-20g, Fructus Lycii 10-20g, Radix Polygoni Multiflori Preparata 10-20g, Cortex Moutan 10-20g, Radix Salviae Miltiorrhizae 20-30g, Rhizoma Atractylodis Macrocephalae (parched) 5-15g, Poria 5-15g, Herba Epimedii 5-15g, Ramulus Cinnamomi 5-15g, Radix Angelicae Sinensis 15-25g, Radix Glycyrrhizae Preparata 5-10g.
2. one according to claim 1 treats medicaments for coronary disease formula and using method thereof, it is characterized in that: described Radix Codonopsis is 20g, and the Radix Astragali is 30g, Rhizoma Chuanxiong is 15g, and Fructus Lycii is 15g, and Radix Polygoni Multiflori Preparata is 15g, Cortex Moutan is 15g, Radix Salviae Miltiorrhizae is 25g, and Rhizoma Atractylodis Macrocephalae (parched) is 10g, and Poria is 10g, Herba Epimedii is 10g, Ramulus Cinnamomi is 10g, and Radix Angelicae Sinensis is 20g, and Radix Glycyrrhizae Preparata is 8g.
3. one according to claim 1 treats medicaments for coronary disease formula and using method thereof, it is characterized in that: described using method is by after said medicine on request proportioning, decocting, every day 1 dose, and point 1 to 2 time oral, within 20 days, is a course for the treatment of.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201410691260.8A CN104474129A (en) | 2014-11-26 | 2014-11-26 | Medicinal formula for treating coronary heart disease and use method thereof |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201410691260.8A CN104474129A (en) | 2014-11-26 | 2014-11-26 | Medicinal formula for treating coronary heart disease and use method thereof |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN104474129A true CN104474129A (en) | 2015-04-01 |
Family
ID=52748830
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201410691260.8A Pending CN104474129A (en) | 2014-11-26 | 2014-11-26 | Medicinal formula for treating coronary heart disease and use method thereof |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN104474129A (en) |
Cited By (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN105055836A (en) * | 2015-08-07 | 2015-11-18 | 赵继民 | Medicine formula for treating coronary heart disease and encephalopathy |
| CN107126535A (en) * | 2017-05-17 | 2017-09-05 | 王湧钢 | The application process that plant extracts is cured the disease in tcm field, health, health care are new |
| CN108853367A (en) * | 2018-10-06 | 2018-11-23 | 刘仪龙 | A kind of Chinese medicine preparation for treating each phase coronary heart disease and its five internal organs loss |
Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101804183A (en) * | 2010-05-26 | 2010-08-18 | 唐平成 | Medicine for treating coronary heart disease |
| EP2586452A1 (en) * | 2010-06-28 | 2013-05-01 | Tasly Pharmaceutical Group Co., Ltd. | Use of a chinese medicine composition in preparing medicaments for treating secondary prevention of myocardial infarction |
-
2014
- 2014-11-26 CN CN201410691260.8A patent/CN104474129A/en active Pending
Patent Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101804183A (en) * | 2010-05-26 | 2010-08-18 | 唐平成 | Medicine for treating coronary heart disease |
| EP2586452A1 (en) * | 2010-06-28 | 2013-05-01 | Tasly Pharmaceutical Group Co., Ltd. | Use of a chinese medicine composition in preparing medicaments for treating secondary prevention of myocardial infarction |
Non-Patent Citations (2)
| Title |
|---|
| 杨瑞平: "浅谈冠心病之用药规律", 《光明中医》 * |
| 白苏子等: "《中华实用奇方全书》", 30 September 2013, 黑龙江科学技术出版社 * |
Cited By (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN105055836A (en) * | 2015-08-07 | 2015-11-18 | 赵继民 | Medicine formula for treating coronary heart disease and encephalopathy |
| CN107126535A (en) * | 2017-05-17 | 2017-09-05 | 王湧钢 | The application process that plant extracts is cured the disease in tcm field, health, health care are new |
| CN107126535B (en) * | 2017-05-17 | 2018-05-01 | 王湧钢 | The application process that plant extracts is cured the disease in tcm field, health, health care are new |
| CN108853367A (en) * | 2018-10-06 | 2018-11-23 | 刘仪龙 | A kind of Chinese medicine preparation for treating each phase coronary heart disease and its five internal organs loss |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN104083740A (en) | Internal traditional Chinese medicament for gaining weight | |
| CN104940740A (en) | Traditional Chinese medicine composition for treating polycystic ovarian syndrome and preparation method thereof | |
| CN103432559B (en) | Traditional Chinese medicine composition for treating spanomenorrhea and dysmenorrhea caused by blood stasis and preparation method and application thereof | |
| CN101524470B (en) | Traditional Chinese medicine preparation for curing angiocardiopathy stent restenosis and preparation method thereof | |
| CN104306540B (en) | A kind of treat Chinese medicine preparation of numb limbs and tense tendons and preparation method thereof after brain tumor surgery | |
| CN104474129A (en) | Medicinal formula for treating coronary heart disease and use method thereof | |
| CN103919910A (en) | Medicine for treating coronary heart disease | |
| CN104173957A (en) | Anti-senile life-prolonging plaster | |
| CN105687788A (en) | Pharmaceutical composition capable of softening blood vessels and application thereof | |
| CN104353051A (en) | Traditional Chinese medicine preparation for treating stomachache and preparation method thereof | |
| CN104367926A (en) | Traditional Chinese medicine preparation for treating predawn diarrhea and preparation method thereof | |
| CN103860773A (en) | Traditional Chinese medicine composition for treating myocardial ischemia and preparation method thereof | |
| CN104042981A (en) | Medicament for treating postnatal constipation and preparation method thereof | |
| CN203252935U (en) | Anti-senile and life-prolonging plaster | |
| CN112494614A (en) | Chinese medicinal formula for preventing and treating cancer by using combination of pawpaw and various medicines | |
| CN104840773A (en) | Traditional Chinese medicine composition for treating vertebral artery type cervical spondylopathy and method for preparing same | |
| CN104666999A (en) | Traditional Chinese medicine formula capable of reducing blood pressure | |
| CN104127670A (en) | Traditional Chinese medicine decoction for treating arrhythmia | |
| CN102641420B (en) | Pharmaceutical composition for treating coronary heart disease | |
| CN103341108B (en) | Pharmaceutical composite for treating stress urinary incontinence after prostatectomy | |
| CN1219047C (en) | Ginseng jade health care wine | |
| CN104888182A (en) | Traditional Chinese medicine preparation for treating postpartum abdominal pain and preparation method therefor | |
| CN106389821A (en) | Traditional Chinese medicine preparation for treatment of blood transfusion hemolytic reaction and preparation method thereof | |
| CN104707003B (en) | The Chinese medicinal capsule for the treatment of hypertension, hyperlipidemia | |
| CN105663679A (en) | Traditional Chinese medicine composition for treating ichthyosis |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| RJ01 | Rejection of invention patent application after publication |
Application publication date: 20150401 |
|
| RJ01 | Rejection of invention patent application after publication |